Skip to Content
거시경제 📉 부정적

‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

요약

Mike Doustdar says he is open to ‘large’ deals and group will suffer ‘failures’ as it tries to cut reliance on weight-loss drugs